SYDNEY / NEW YORK (Reuters) – The news of an effective vaccine against the new Coronavirus is fueling bets on global economic recovery Large segments of the market have suffered under nearly nine months from the COVID-19 pandemic
Pfizer Inc said Monday that its experimental COVID-19 vaccine was more than 90% effective, a major potential victory in fighting the pandemic that has killed more than a million people, knocked out the global economy and brought daily life upside down.
Pfizer and its German partner BioNTech SE expect to search for a US license this month for emergency use of the vaccine, increasing the possibility of a regulatory decision taken as soon as December
Investors piled up in shares of banks, airlines and other economically sensitive companies that have been hit by months of closures and travel bans due to the Coronavirus, pushing the Dow Jones Industrial Average and S&P 500 to new record highs, while they were sold Havens such as gold, the Japanese yen, and the Ux T-yield curve slope
For several months, many investors have seen the development of an effective vaccine against COVID-19, which has claimed the lives of one person 2 million people worldwide, as the most important catalyst for the global economic recovery and the next major transformation in financial markets
The prospect of getting an effective vaccine sometime next year could force investors to reassess a raft of recent bets, ranging from how much fiscal stimulus lawmakers might need to provide to whether the Fed will keep interest rates near historic lows. For a long time As previously expected
It could also weaken the attractiveness of large technology and momentum stocks, whose returns have proven flat during the pandemic. Some of those huge stocks, like Amazoncom , were underperforming on Monday
“I think this really requires two major forms of uncertainty – the health impact of COVID and the economic impact of COVID – and it creates a pathway now that I think investors can see to progress and restore our health and our economy,” said Jack Ablin, chief investment officer at Cresset Capital Management
Pfizer awaits more complete safety data before emergency request U o Vaccine approval If a vaccine is approved, logistical challenges are likely to undermine distribution while many Americans hold skepticism about vaccines that can prevent widespread vaccination
p>
“We still have a long way to go,” said Nigel Green, chief executive of Devere Group, in a note to investors. “I would urge investors to stay optimistic and avoid the ‘buy-in’ mentality. »
Investors expected that an effective vaccine could be a catalyst for industries hindered by economic shutdowns designed to control the coronavirus pandemic.These include airlines, cruise ships, hotels and casinos, all of which rose on Monday
The widespread deployment of an effective vaccine may also lift sectors perceived to be particularly sensitive to the economy, including the energy, financial and industrial sectors Amid S&P 500 gains on Monday, these sectors were outperforming
“What we did is give ourselves some options for the recovery trade, or the vaccine trade, through exposure to some financial issue” of the vaccine, Binay Chandgothia, Hong Kong Portfolio Manager at Principal Global Investors, said before the news.
He said that banks are benefiting from increased economic activity and will be helped if bond yields rise, adding that he has increased exposure to growth-sensitive small companies and will buy stocks in Singapore and Hong Kong if trade and travel boom
Brian Jacobsen, chief investment strategist at Wells Fargo Asset Management in Wisconsin, said before the vaccine news was published that industries exhibited broad exposure to rebounding confidence in areas from product building to aviation.
Some global investors have also staged plays before Monday that will capitalize on the potential shift in market leadership that a vaccine can bring.
Shinji Naito of Japan’s SPARX Asset Management, which manages $ 12 billion, hopes the vaccine will gain from the stock shortage pumped by the pandemic, such as some tech companies, while helping in long-term investments such as real estate broker Tokyo Tatimono , He said that before Monday’s news.
(Prepared by Tom Westbrook in Singapore, Elizabeth Hawcroft in London and Louis Krauskopf in New York, written by Ira Eusbashvili; edited by Vidya Ranganathan, Sam Holmes, and Edward Tobin)
Former Vice President Biden has made a detailed proposal that includes tax increases for people whose taxable income exceeds $ 400,000 – mainly targeting the top 1% President Trump wants to keep the tax cuts that went into effect in 2018, which the owners have benefited from Significantly high income
Democratic presidential candidate Joe Biden’s victory in the November election could change the tax bills for so many Americans here’s what you need to know
Quinn analyst Geoffrey Osborne released a buy valuation Monday and sees stocks reach $ 22, up from Friday’s closing price of $ 10.86
Stocks sailed to record highs on Monday morning as traders took promising data on a leading COVID-19 vaccine candidate in addition to President-elect Joe Biden’s victory in the US presidential election, which ended with long days of harassment for any candidate who would win the White House
Nio got bullish endorsement from JR Rebecca Wayne, Morgan analyst, raising its share price target based on the belief that the Shanghai-based company will be the « winner » in the electric vehicle market
The Dow Jones Industrial Average rose after the PFE announced that the Covid-19 vaccine has a 90% efficacy rate. The Dow rose to 11,088 points, or about 39% following the announcement. The S&P 500 also gained about 29% points, while the index rose. Nasdaq composite 12% with household stocks hurt
Joe Biden is now the president-elect, but unlike a previous Trump statement, the coronavirus is far from yesterday’s news after a potential Democrat victory. News of the spike in Covid-19 cases may have subsided during last week’s election frenzy, but the global battle against taming The epidemic has not yet won, but how close are we to achieving the desired vaccine? The race is still the first to market a solution as many names have candidate vaccines in Advanced Studies (MRNA). Moderna remains one of the leaders, with the COVID-19 Candidate vaccine mRNA-1273, currently in Phase 3 trials, after meeting with the Head of Relationships. Investors in Moderna, Oppenheimer analyst Hartag Singh believes the company is still on track to reveal interim data in the next few weeks Singh said: “A uselessness analysis will also be done at that time, but we think the odds are slim (<5%). ) Against this negative reading, based on preclinical and clinical data published to date 'If the provisional data proves to be positive, Singh says potential emergency use licensing by the Food and Drug Administration (EUA) and prior US approvals "should happen quickly." While it is not surprising that the development of mRNA-1273 is currently taking center stage, Moderna Also progressing with other vaccination programs The company recently announced that it will start developing a vaccine against seasonal influenza. Singh says the flu vaccine space is an "interesting new business area", with global sales estimated at $ 4 billion, and Singh indicates "the true likelihood of approval of an MRNA flu vaccine." Just in time for the 2022 influenza season, ”he considers it another reason to“ stay optimistic ”in stock. The analyst concluded,“ We are still a fan of the MRNA platform that is scalable and implemented across different pipeline candidates. ”“ We love the big picture of MRNA in 2021, especially as a potential company Income-generating starting in 2021 (with DTAs of $ 982 million net worth of & NOLs worth $ 471 million as of year 19) Profit can also attract the attention of another class of investors. N Most importantly, mRNA-1273 approval can validate the overall prophylactic vaccine privilege overall 'bullish tone is reflected by iterating outperformance (i e buy) and price target is $ 108, implying a 40% upside (to see Singh’s record, click here) Majority of street analysts support Singh's call based on 9 buys and 1 contract and sell, each with a consensus rating of Average Buy at $ 98 At $ 20, the average target price indicates a potential spike of approximately 27% over the following months (see Moderna stock analysis At TipRanks) To find good ideas for trading healthcare stocks with attractive reviews, visit Best Stocks to Buy from TipRanks, a newly launched tool that unites all share insights for TipRanks Disclaimer: The opinions in this article are only those of the premium analyst. The content is intended for use. Informational only It is very important to do your own analysis before making any investment
With pension plans fading, investors today may want to look to pensions to bridge the retirement gap, one expert said.
Goldman Sachs thinks receiving positive news on the COVID-19 front is essential to keeping the stock market rally after the election
When searching for the best AI stocks to buy, identify companies that are using AI technology to improve products or gain a strategic advantage, such as Microsoft, Netflix, and Nvidia
Zoom shares, which have risen fivefold since the start of the year, plunged more than 17% at the start of trading on Monday after the online meeting group reached a privacy settlement with the Federal Trade Commission
Joe Biden is the President-elect now verifying the IRA’s investments and the 401 (k) that should get a boost from Biden’s win
The energy sector is booming, but refiners may be the first to see the impact of the good news on their business
Tesla lags behind domestic Chinese players in a hot Chinese market for electric cars but Tesla shares rose early Monday as it works on Abuy Point
Workhorse started its earnings from electric vehicle stocks but Workhorse stock declined as it gave weak direction to production in the fourth quarter Nicolas Deserved
Will Democrats hurt the stock market? No, say professionals at Wall Street, although some investors have expressed concern about how the president-elect’s policies affect stocks, as well as the effect of a potential « blue wave », dominated by Democrats in the White House, Senate and Congress, analysts have historically said that stocks Outperforming regardless of which party controls the White House or Congress Looking at data from the past 78 years, party control had a limited impact on the broader S&P 500 Starting in 1942, the data shows that the Republican and Democratic majorities in the House and Senate had little impact On stock prices in the two-year period after the election The same is true when comparing the number of gained or lost party seats in the House and Senate with share prices for S&P 500 during that period. Similar results are seen in the period from November to November, which is a measure of market sentiment towards the elections. With all this in mind, we used a database. TipRanks As we search for compelling plays by relying on two in particular, the platform has identified two stocks that have received overwhelming bullish praise from the street, enough to win the consensus of Atlanta-based PulteGroup (PHM) PulteGroup analyst is the third largest. To build homes in the United States, where they generate about $ 10 billion in annual revenue, the economic expansion we’ve seen over the past three years has been beneficial to the company, as wage growth and expansion in the labor market put money in people’s hands. The COVID-19 pandemic struck during the first quarter of the year. Year, and PulteGroup saw a drop in profits and revenues – but the first quarter was the slowest company over the year, with net profits rising during the fourth quarter not only continuing P HM is following this pattern, but the quarterly results in 2020 consistently beat expectations and posted annual gains in the third quarter, the most recent report reported, EPS was $ 1 34, the highest in more than two years, in terms of revenue of $ 2 95 billion. The stock price, PHM fell in February / March, along with the overall markets, but the stock has been rising since then PHM hit its lowest level on March 23, and over the past seven and a half months it has rebounded 148%, writes analyst Michael Dahl, who RBC Capital’s PHM covers, “While growth at the moment is the rage, the balanced and yield-based PHM model has historically required a stronger premium, and we expect this to return in the coming months as investors shift their focus looking at more challenging companies.” And community statistic trends and inflationary pressures across the peer group most importantly, that PHM remains in a good position on the ground with more than 7 years in control (53% owned, 47% optional), which is positive in a land-limited and inflated environment; Combined with pricing strength, this should allow it to maintain GM> 24%. ”Dahl ranks the stock as an outperformer (i e buy) and its $ 53 target price points to a 22% rally for the next year (to see Dahl’s record, click here) visually. General, PulteGroup has a strong buying rating from analyst consensus, based on 6 buys and 2 contracts set in recent weeks: $ 43 a share 12 trading price and $ 55 67 average target price means a one-year upside of 225% (see PHM stock analysis At TipRanks) Dynatrace, Inc (DT) With our second inventory, we’re moving into the world of artificial intelligence. Dynatrace is an AI company that provides cloud platforms that monitor and manage business programs. The company’s AI can manipulate the infrastructure in system architecture and cloud software, making it a comprehensive network management tool. Seeking to reduce system stress The popularity of Dynatrace products only grew during the Coronavirus crisis as white-collar desks make a strong shift toward working remotely and virtual desktops, robust systems management has become a valuable commodity ever since it was reported. In mid-March, DT shares showed investors a healthy recovery. The stock has risen 90% since its lowest level in March. This stock covers Needham, Jack Andrews describes Dynatrace as the right company in the right place at the right time « [with] issuance cycles accelerate and services become hybrid , The demand for DT is increasing due to the increasing complexity of enterprise systems The DT platform provides automation / artificial intelligence to alert and dynamically monitor the structure of systems. We believe the suitability of a DT product may enable it to capture a large mix of AI-enabled enterprise workloads as it replaces the existing tool and with customers expanding into additional modules, ”Andrews said in line with his comments, Andrews appointed DT buy rating, price target of $ 50 indicates confidence in a one-year rise of 61% (to see Andrews record, click here) Overall, Wall Street liked this stock, and had a consensus rating from excellent analysts, as TipRanks’ analysis showed that DT is a strong buy out of 11 analysts tracked by TipRanks in the past three months, 10 were bullish, while only 1 remained on the sidelines with a potential return of nearly 34%, the agreed target price for the stock stands at $ 50 36 (see DT Stock Analysis At TipRanks) To find good stock trading ideas with attractive reviews, visit Best Stocks to Buy from TipRanks, a newly launched tool that unites all the stock insights for TipRanks Disclaimer: The opinions presented in this article e Only the opinions of distinguished analysts. The content is intended for informational purposes only. It is very important to do your own analysis before making any investment.
Together with the rest of Wall Street, you will indulge in the euphoria that accompanies a bull market at the last stage. It has been more than a month since the stock market reached its all-time high, and it is possible that the last revolutionary moment has occurred. Time – and that a new bear market has already started. While this does not mean that a new bear market has started, it also does not mean that the market has not started.
On CNBC’s « Mad Money Lightning Round », Jim Kramer said he would choose First Solar Inc (NASDAQ: FSLR) over Solaredge Technologies Inc (Nasdaq: SEDG) Plantronics Inc. (NYSE: PLT) is a good company and high stock Quality, he also said he prefers lower-tier companies, more gaming-oriented, but he doesn’t want to clash with the call and thinks Plantronics is a good company Workhorse Group Corporation (NASDAQ: WKHS) is kind of a show for Kramer if he wanted EV stock, he’d buy Plug Power. Inc (NASDAQ: PLUG) instead of Moneygram International Inc (NASDAQ: MGI), Jim Cramer will buy Paypal Holdings Inc (NASDAQ: PYPL) because it deals with cryptocurrencies (NYSE: PANW) and Crowdstrike Holdings Inc. (NASDAQ: CRWD) Kramer hits the table to buy Alibaba Group Holdings Ltd. (NYSE: PANW) Troopanion Corporation (NASDAQ: TRUP) is also a good thing, Kramer said – he thinks we need To see pet insurance, see more of Benzinga * click e Here for options deals from Benzinga * Carter Worth and Mike Khouw watch SLV Moving Higher * Tony Chang sees bullish sign for US Water Works (C) 2020 Benzinga.com does not provide Benzinga investment advice All rights reserved
The supermarket chain Nordstrom has seen stocks drop nearly 70% this year, but analyst Dana Telsey raised the stock to Outperform she likes « Nordstrom’s strong financial position »
Vaccine, Stocks, Investor, Finance, Moderna, Economic Recovery, Pfizer
World News – California – Vaccine News cuts investors’ bets on economic recovery
SOURCE: https://www.w24news.com
